Oxidative stress is the main factor in doxorubicin (DOX) induced cardiotoxicity. Wistar rats received either DOX (3mgkg(-1), i.p.) every other day or combination of Hypericum hircinum (100 and 200mgkg(-1), p.o.) and DOX or H. hircinum (200mgkg(-1), p.o.) extract alone for 2 weeks. Cardiotoxicity was assessed by recording changes in ECG, heart rate and measuring the levels of cardiac marker enzymes - lactic acid dehydrogenase, creatine phosphokinase, glutamic oxaloacetic transaminase, the antioxidant defence enzymes - reduced glutathione (GSH), superoxide dismutase (SOD) and lipid peroxidative value (LPO) at the end of treatment schedule. Treatment with H. hircinum significantly (p<0.05) decreased the levels of LPO and marker enzymes, increased the levels of GSH and SOD, reversed the changes in ECG and prevented the decrease in heart weight in DOX-treated group. The results suggest that H. hircinum has the potential to prevent the cardiotoxic effects induced by DOX.

Protective effect of Hypericum hircinum on doxorubicin-induced cardiotoxicity in rats

BALLERO, MAURO;MAXIA, ANDREA;SANNA, CINZIA
2013-01-01

Abstract

Oxidative stress is the main factor in doxorubicin (DOX) induced cardiotoxicity. Wistar rats received either DOX (3mgkg(-1), i.p.) every other day or combination of Hypericum hircinum (100 and 200mgkg(-1), p.o.) and DOX or H. hircinum (200mgkg(-1), p.o.) extract alone for 2 weeks. Cardiotoxicity was assessed by recording changes in ECG, heart rate and measuring the levels of cardiac marker enzymes - lactic acid dehydrogenase, creatine phosphokinase, glutamic oxaloacetic transaminase, the antioxidant defence enzymes - reduced glutathione (GSH), superoxide dismutase (SOD) and lipid peroxidative value (LPO) at the end of treatment schedule. Treatment with H. hircinum significantly (p<0.05) decreased the levels of LPO and marker enzymes, increased the levels of GSH and SOD, reversed the changes in ECG and prevented the decrease in heart weight in DOX-treated group. The results suggest that H. hircinum has the potential to prevent the cardiotoxic effects induced by DOX.
2013
Antioxidant defence enzyme; Cardiac marker enzymes; Doxorubicin; H. hircinum
File in questo prodotto:
File Dimensione Formato  
2013 - Hypericum hircinum-NPR.pdf

Solo gestori archivio

Tipologia: versione editoriale (VoR)
Dimensione 378.05 kB
Formato Adobe PDF
378.05 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/51464
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact